Morgan Stanley

Unilever, the UK-Dutch consumer goods company, highlighted growing demand for short dated bonds and FRNs on Wednesday, when it gathered a hefty order book at arguably no new issue premium for a three year floater.

BNP Paribas is set to lose two experienced traders from its flow credit business in London.

A Nordic agency is set to tackle the 10 year part of the dollar curve — a tenor SSAs have largely shunned so far in May.

BSN Medical, the German bandage maker, has won a strong response to its new term loan 'C', and has decided to cut pricing on both that and a pre-existing term loan 'B'.

The Republic of Ukraine priced a $1bn five year US AID backed deal on Tuesday — it’s second such transaction — and Ukrainian analysts expect another $1bn deal before the end the year.

The public sector borrower market is enjoying stability after weeks of turbulence, with a pair of issuers trebling the number of euro benchmarks so far this month.

Chinese biotech firm 3SBio has bagged $150m from some heavyweight cornerstone investors including GIC and BlackRock ahead of launching its HK$5.51bn ($712m) Hong Kong IPO, putting the company’s second flotation on a very strong footing.

China Hengshi Foundation Co, a manufacturer of fibreglass fabrics used in wind turbine blades, has filed its draft prospectus to list in Hong Kong in a deal led by sole sponsor Morgan Stanley.

ING Group launched a €1.18bn sale of shares in NN Group, its former insurance and investment arm, on Tuesday evening, in the larger of two block trades of the day.

Two public sector borrowers have picked banks to run dollar deals on Wednesday — and even more deals could follow, said SSA bankers.

Eli Lilly, the US pharmaceuticals company, made its euro bond debut on Tuesday, printing seven, 11 and 15 year notes and proving that the market is still open for longer dated paper — at a price.

Egypt has set roadshow dates for its 144A/Reg S bond.